NCT01733147 2022-01-11
Modulation of Esophageal Inflammation in Barrett's Esophagus by Omega-3 Fatty Acids
Mayo Clinic
Phase 4 Completed
Clinical Trials
7 trialsNCT01093755 2016-03-17
Does Intensive Acid Suppression Reduce Esophageal Inflammation and Recurrent Barrett's Esophagus Following Ablation?
Mayo Clinic
Phase 4 Completed
NCT00754468 2015-11-04
ESODOI
CSA Medical, Inc.
Phase 4 Completed
NCT00637559 2011-01-25
Barrett's Esophagus - 315 - 3 Way Cross-Over
AstraZeneca
Phase 4 Completed
NCT00637988 2011-01-21
Barrett's Esophagus - 315 - 3 Way Cross Over
AstraZeneca
Phase 4 Completed
NCT00872755 2009-03-31
Nissen and Gastroplasty in Gastroesophageal Reflux Disease (GERD)
G. Hatzikosta General Hospital
Phase 4 Completed
NCT00352261 2009-03-26
An Open Label pH Comparison of Esomeprazole and Lansoprazole in Barrett's Esophagus Patients
AstraZeneca
Phase 4 Completed